Lung Cancer Screening

CHF 83.95
Auf Lager
SKU
NI4RFON9GEJ
Stock 1 Verfügbar
Geliefert zwischen Mi., 22.04.2026 und Do., 23.04.2026

Details

Lung cancer is the leading cause of cancer-related death among men and women in the U.S. and worldwide. For many decades, lung cancer was the sole cancer among the deadly four without an evidence-based screening method for decreasing mortality. This changed in November 2011, when findings from the National Lung Cancer Screening Trial showed low-dose lung CT screening was more efficacious in reducing deaths in high-risk individuals than conventional radiography. As such, an ever-increasing number of health organizations now recommend this screening protocol.

Lung Cancer Screening by Mark Parker and esteemed VCU Health colleagues, fulfills the dire need for a comprehensive guide explaining the crucial aspects of lung cancer screenings. The first two chapters lay a foundation with discussion of lung cancer epidemiology and risk factors beyond cigarette smoking. Subsequent chapters cover the fundamentals, with clinical pearls on setting up a successful lung cancer screening program, patient eligibility criteria, imaging variances of tumors in the lungs, screening pros and cons, and interpreting/reporting screening results.

  • The evolution and future of lung cancer screenings
  • Detection and management of unexpected incidental pulmonary and non-pulmonary findings
  • Discussion of test cases utilizing the Lung-RADSTM risk-stratifying system for low-dose chest CT screenings
  • Benefits and potential harms associated with mass lung cancer screening programs including false positive, false negative, and over-diagnosis rates
    This state-of-the-art guide is essential reading for radiologists, oncologists, pulmonologists, and internists. It is a must-have bookshelf reference for hospital radiology and oncology departments, in particular for those setting up new lung cancer screening programs.

    Inhalt

    1 Lung Cancer Epidemiology
    2 Risk Factors for Lung Cancer
    3 Evolution of Lung Cancer Screening
    4 Lung Cancer Screening Pros and Cons
    5 Variable Imaging Presentations of Lung Cancer
    6 Lung CancerScreening Results Reporting
    7 Detection and Management of Unexpected Incidental Pulmonary and Nonpulmonary Findings
    8 Elements of a Successful Lung CancerScreening Program
    9 Future of Lung Cancer Screening
    10 Test Cases: Applying Lung CT Screening Reporting and Data System (Lung-RADS)

Weitere Informationen

  • Allgemeine Informationen
    • GTIN 09781626235137
    • Schöpfer Mark S. Parker, Robert C. Groves, Joanna E. Kusmirek, Leila Rezai Gharai, Samira Shojaee
    • Sprache Englisch
    • Auflage New ed
    • Größe H231mm x B153mm x T9mm
    • Jahr 2017
    • EAN 9781626235137
    • Format Kartonierter Einband
    • ISBN 978-1-62623-513-7
    • Veröffentlichung 12.12.2017
    • Titel Lung Cancer Screening
    • Autor Mark Parker , Robert Groves , Joanna Kusmirek
    • Gewicht 302g
    • Herausgeber Georg Thieme Verlag
    • Anzahl Seiten 120
    • Lesemotiv Verstehen
    • Genre Medical Books

Bewertungen

Schreiben Sie eine Bewertung
Nur registrierte Benutzer können Bewertungen schreiben. Bitte loggen Sie sich ein oder erstellen Sie ein Konto.
Made with ♥ in Switzerland | ©2025 Avento by Gametime AG
Gametime AG | Hohlstrasse 216 | 8004 Zürich | Schweiz | UID: CHE-112.967.470
Kundenservice: customerservice@avento.shop | Tel: +41 44 248 38 38